Randomized, Placebo Controlled, Crossover Clinical Study to Analyse the Effect of Dapagliflozin on Microvascular and Macrovascular Circulation and Total Body Sodium Content

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 25 Jan 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

01 Dec 2021 Results published in the Journal of Diabetes and its Complications
30 Aug 2017 Results assessing the effect of dapagliflozin on tissue sodium content, presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology
16 Nov 2016 Results assessing the sodium content in the skin and muscles of the lower leg by the Na-MRI at baseline, presented at the 89th Annual Scientific Sessions of the American Heart Association.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com